Monoamine oxidase inhibitors are liable for blocking the monoamine oxidase enzyme. The monoamine oxidase enzyme breaks down differing kinds of neurotransmitters from the brain: norepinephrine, serotonin, dopamine, and tyramine. In addition, it inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels. Potential added uses of Safinamide may be Parkinson's disease, https://horacen776yku9.wiki-cms.com/user